BR6002

DRUG2 trials

Sponsors

Boryung Pharmaceutical Co., Ltd

Conditions

Gastric or Duodenal UlcerGastric or Duodenal Ulcers

Phase 1

A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of BR6002 and Coadministration of BR6002A and BR6002B Under Fasting Conditions in Healthy Adult Volunteers

CompletedNCT05959486

Boryung Pharmaceutical Co., LtdGastric or Duodenal Ulcers

Start: 2023-07-14End: 2023-08-24Updated: 2023-12-05

A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of BR6002 and Coadministration of BR6002A and BR6002B Under Fed Conditions in Healthy Adult Volunteers

CompletedNCT05959499

Boryung Pharmaceutical Co., LtdGastric or Duodenal Ulcer

Start: 2023-07-13End: 2023-09-12Updated: 2023-11-18